Vulvar and Vaginal Cancer Deaths Rise in Brazil – 2025 Data
Summary of the Article: HPV-Related Cancers in Brazil
This article discusses the rising incidence of vulvar and vaginal cancers in Brazil, strongly linked to HPV (Human papillomavirus) infection. Here’s a breakdown of the key points:
* Increasing Numbers: Between January and September of an unspecified year (likely 2025 based on mentions), brazil recorded 597 deaths related to vulvar and vaginal cancers. There were also 16,559 outpatient visits and 2,161 hospitalizations.
* HPV as a Major factor: HPV is identified as the main risk factor for these cancers, accounting for around 4.5% of all cancers globally (approximately 630,000 new cases annually).
* Regional Disparities: São paulo state has the highest number of deaths from vulvar cancer (521), possibly due to better access to specialized services. The South region has a high concentration of vulvar cancer deaths (400), while the North has the fewest (75). Most vaginal cancer deaths occur in the Southeast region.
* Stigma and Prevention: The article highlights that stigma surrounding HPV hinders prevention efforts,as patients delay seeking medical help due to judgment.
* Distinction between Vulva and Vagina: the article clarifies the difference between the vulva (external genitalia) and the vagina (internal canal), noting that confusion is common.
* Causes & Types: Vulvar cancer has two main origins: HPV infection (common in women 45-55) and lichen sclerosus (an inflammatory disease, more common in younger/older women). Lichen sclerosus can develop into cancer in up to 60% of cases if untreated, but risk is considerably reduced with corticosteroid treatment.
* Symptoms: Initial symptoms are often non-specific.
In essence, the article emphasizes the importance of HPV prevention, early detection, and addressing the stigma associated with these cancers to improve outcomes for women in Brazil.